Stelios Papadopoulos's Net Worth
$NaN
Who is Stelios Papadopoulos?
Stelios Papadopoulos has an estimated net worth of $NaN. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., SGX PHARMACEUTICALS, INC., EXELIXIS, INC., BG Medicine, Inc., Eucrates Biomedical Acquisition Corp., Regulus Therapeutics Inc., ANADYS PHARMACEUTICALS INC, GENVEC INC, and DIACRIN INC /DE/.
SEC CIK
Stelios Papadopoulos's CIK is 0001202098
Past Insider Trading and Trends
2010 was Stelios Papadopoulos's most active year for acquiring shares with 30 total transactions. Stelios Papadopoulos's most active month to acquire stocks was the month of April. 2011 was Stelios Papadopoulos's most active year for disposing of shares, totalling 28 transactions. Stelios Papadopoulos's most active month to dispose stocks was the month of October. 2013 saw Stelios Papadopoulos paying a total of $3,227,463.25 for 470,476 shares, this is the most they've acquired in one year. In 2013 Stelios Papadopoulos cashed out on 95,370 shares for a total of $8,483,635.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $200.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.76% | 2.25K |
—
|
—
| 10.1K |
Jun 15
| |||
Form 4
| +19.42% | 1.27K |
—
|
—
| 7.84K |
Jul 1
| |||
Form 4
| +28.85% | 1.47K |
—
|
—
| 6.57K |
Jun 3
| |||
Form 4
| +59.72% | 1.91K |
—
|
—
| 5.09K |
Jun 19
| |||
Form 4
| +83.33% | 1.45K |
—
|
—
| 3.19K |
Jun 12
| |||
Form 4
| +9.56% | 1.74K |
—
|
—
| 19.95K |
Jun 7
| |||
Form 4
| +9.59% | 1.59K |
—
|
—
| 18.17K |
Jun 8
| |||
Form 4
|
∞
| 10K |
$304.88 | $3,048,775.00 | 10K |
Jul 27
| |||
Form 4
| +6.69% | 1.04K |
—
|
—
| 16.58K |
Jun 10
| |||
Form 4
| +9.17% | 1.3K |
—
|
—
| 15.54K |
Jun 12
| |||
Form 4
| -4.78% | -715.00 |
$219.62 | -$443,632.40 | 14.23K |
Scheduled
|
Jun 11 - Jun 12
| ||
Form 4
|
—
|
0
|
$115.35 | -$5,312,539.47 | 14.95K |
Scheduled
|
Mar 11
| ||
Form 4
| +15.62% | 2.02K |
—
|
—
| 14.95K |
Jun 8
| |||
Form 4
| +28.91% | 2.9K |
—
|
—
| 12.93K |
Jun 1
| |||
Form 4
| +133.53% | 5.74K |
—
|
—
| 10.03K |
Jun 9
| |||
Form 4
| +109.51% | 2.25K |
—
|
—
| 4.29K |
Jun 3
| |||
Form 4
|
∞
| 2.05K |
—
|
—
| 2.05K |
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SGX PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 35.93K |
—
|
—
| 35.93K |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXELIXIS, INC. (EXEL) Snapshot price: $25.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.49% | 18.84K |
—
|
—
| 1.28M |
May 31
| |||
Form 4
| +0.02% | 249 |
$20.29 | -$11,481.98 | 1.26M |
May 20
| |||
Form 4
| +1.67% | 20.72K |
—
|
—
| 1.26M |
Jun 1
| |||
Form 4
| +1.60% | 19.57K |
—
|
—
| 1.24M |
May 26
| |||
Form 4
| -6.48% | -84.52K |
$19.56 | -$1,653,113.40 | 1.22M |
Feb 22
| |||
Form 4
| +1.28% | 16.42K |
—
|
—
| 1.3M |
May 27
| |||
Form 4
| +8.35% | 99.23K |
$14.63 | -$6,393.63 | 1.29M |
May 11
| |||
Form 4
| +1.32% | 15.54K |
—
|
—
| 1.19M |
May 21
| |||
Form 4
| +11.48% | 120.79K |
$5.82 | $703,003.62 | 1.17M |
May 13
| |||
Form 4
|
—
|
0
|
$15.44 | -$936,600.00 | 1.05M |
May 8
| |||
Form 4
| +0.99% | 10.32K |
—
|
—
| 1.05M |
May 23
| |||
Form 4
|
—
|
0
|
$12.82 | -$442,462.50 | 1.04M |
Feb 21
| |||
Form 4
| +0.77% | 7.94K |
—
|
—
| 1.04M |
May 24
| |||
Form 4
|
—
|
0
|
$16.91 | -$157,350.00 | 1.03M |
May 7
| |||
Form 4
|
—
|
0
|
$16.01 | -$241,200.00 | 1.03M |
Mar 2
| |||
Form 4
| -100.00% | -10.00K |
$25.40 | -$254,000.00 |
0
|
Sep 22
| |||
Form 4
| -16.20% | -200.00K |
$27.68 | -$5,535,387.30 | 1.03M |
Sep 18 - Sep 19
| |||
Form 4/A
| +0.48% | 5.84K |
—
|
—
| 1.23M |
May 25
| |||
Form 4
| +0.48% | 5.84K |
—
|
—
| 1.23M |
May 25
| |||
Form 4
|
—
|
0
|
$16.10 | -$111,300.00 | 1.23M |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +1.24% | 15.07K |
—
|
—
| 1.23M |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| +6.07% | 69.44K |
—
|
—
| 1.21M |
Oct 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +21.19% | 200K |
$3.05 | $610,196.55 | 1.14M |
Aug 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
| +46.71% | 300K |
$3.23 | $968,827.50 | 942.28K |
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BG Medicine, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +26.66% | 250K |
$2.00 | $500,000.00 | 1.19M |
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +19.12% | 150.54K |
$2.02 | -$19.92 | 937.71K |
Nov 29
| |||
Form 4
| +74.64% | 336.44K |
$0.90 | $302,796.90 | 787.17K |
Nov 9
| |||
Form 4
|
∞
| 450.73K |
$7.00 |
—
| 450.73K |
Sep 27 - Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eucrates Biomedical Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.87% | -255.09K |
—
|
—
| 2.62M |
Nov 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||